Gene-modified cells for stem cell transplantation and cancer therapy.
作者信息
Brenner Malcolm K
机构信息
Center for Cell and Gene Therapy at Baylor College of Medicine , Houston Methodist Hospital, and Texas Children's Hospital, Houston, TX 77030.
出版信息
Hum Gene Ther. 2014 Jul;25(7):563-9. doi: 10.1089/hum.2014.2527.
Abstract
摘要
相似文献
1
Gene-modified cells for stem cell transplantation and cancer therapy.
Hum Gene Ther. 2014 Jul;25(7):563-9. doi: 10.1089/hum.2014.2527.
2
[Review and forecast of surgical treatment for coronary artery disease].
Zhonghua Wai Ke Za Zhi. 2006 Nov 15;44(22):1515-6.
3
Stem cell transplantation for multiple myeloma: current and future status.
Hematology. 2012 Apr;17 Suppl 1:S117-20. doi: 10.1179/102453312X13336169156258.
4
Profile: Zhu Jianhong: citizen of the world.
Lancet Neurol. 2008 Mar;7(3):202. doi: 10.1016/S1474-4422(08)70033-4.
5
History of fat grafting: from ram fat to stem cells.
Clin Plast Surg. 2015 Apr;42(2):147-53. doi: 10.1016/j.cps.2014.12.002. Epub 2015 Feb 15.
6
Cardiac regeneration with embryonic stem cells: historic recapitulation of heart transplantation.
Stem Cells Dev. 2008 Dec;17(6):1021-2. doi: 10.1089/scd.2008.0318.
7
The history of the organ transplantation in Romania.
Chirurgia (Bucur). 2010 Sep-Oct;105(5):597-602.
8
The fascinating history of fat grafting.
J Craniofac Surg. 2013 Jul;24(4):1069-71. doi: 10.1097/SCS.0b013e318292c447.
9
Guest Editor John Cooke Lends Expertise on Special Cardiovascular Regeneration Issue.
Methodist Debakey Cardiovasc J. 2015 Jul-Sep;11(3):153. doi: 10.14797/mdcj-11-3-153.
10
Jon Van Rood: pioneer at the crossroad of human leukocyte antigens and transplantation.
Transfus Med Rev. 2007 Apr;21(2):159-63. doi: 10.1016/j.tmrv.2006.11.006.
引用本文的文献
1
Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.
Curr Med Chem. 2024;31(13):1646-1690. doi: 10.2174/0929867330666230503144619.
2
Awakening immunity against cancer: a 2017 primer for clinicians.
Chin J Cancer. 2017 Aug 20;36(1):67. doi: 10.1186/s40880-017-0233-4.
本文引用的文献
1
Genetic diseases, immunology, viruses, and gene therapy.
Hum Gene Ther. 2014 Apr;25(4):257-61. doi: 10.1089/hum.2014.2511.
2
Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene.
Blood. 2014 Jun 19;123(25):3895-905. doi: 10.1182/blood-2014-01-551671. Epub 2014 Apr 21.
3
Rescuing US biomedical research from its systemic flaws.
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5773-7. doi: 10.1073/pnas.1404402111. Epub 2014 Apr 14.
4
Reversal of tumor immune inhibition using a chimeric cytokine receptor.
Mol Ther. 2014 Jun;22(6):1211-1220. doi: 10.1038/mt.2014.47. Epub 2014 Mar 20.
5
Systemic inflammatory response syndrome after administration of unmodified T lymphocytes.
Mol Ther. 2014 Jun;22(6):1134-1138. doi: 10.1038/mt.2014.48. Epub 2014 Mar 21.
6
Hematopoietic stem cell gene therapy: progress on the clinical front.
Hum Gene Ther. 2014 Mar;25(3):165-70. doi: 10.1089/hum.2014.2504. Epub 2014 Feb 28.
7
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Sci Transl Med. 2014 Feb 19;6(224):224ra25. doi: 10.1126/scitranslmed.3008226.
8
Combining drugs and biologics to treat nasopharyngeal cancer.
Mol Ther. 2014 Jan;22(1):8-9. doi: 10.1038/mt.2013.272.
9
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
J Clin Oncol. 2014 Mar 10;32(8):798-808. doi: 10.1200/JCO.2013.51.5304. Epub 2013 Dec 16.
10
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma.
Mol Ther. 2014 Jan;22(1):132-9. doi: 10.1038/mt.2013.242. Epub 2013 Oct 17.
Zotero 插件